patent/WO-2006005017-A3

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12fffd4eafb066e227bbdce4c5a4dc44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edd18b1d2386446f186fa18f3da53ac9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebdaa2ab0f1142c088f482638461e0fe
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate	2005-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc97217d09ebbdde50995b5ba4fac3da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98ae57445428276b91bbff7bca963d0f
publicationDate	2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-2006005017-A3
titleOfInvention	Oral composition comprising carbamylating agent
abstract	The present invention relates to fast release oral compositions containing a carbamylating agent, such as pyridostigmine bromide, a hydrophobic agent and a diluent, and methods of administering and preparing such compositions.
priorityDate	2004-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6248363-B1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7550 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4991 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394085 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426242

Total number of triples: 22.